Market closedADR
Galapagos/$GLPG
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Galapagos
Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.
Ticker
$GLPG
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
704
Website
Galapagos Metrics
BasicAdvanced
$1.7B
19.98
$1.23
-0.01
-
Price and volume
Market cap
$1.7B
Beta
-0.01
52-week high
$27.12
52-week low
$24.39
Financial strength
Current ratio
9.966
Quick ratio
9.567
Long term debt to equity
0.285
Total debt to equity
0.405
Interest coverage (TTM)
-205.37%
Management effectiveness
Return on assets (TTM)
-2.77%
Return on equity (TTM)
-0.05%
Valuation
Price to earnings (TTM)
19.982
Price to revenue (TTM)
5.364
Price to book
0.52
Price to tangible book (TTM)
0.57
Price to free cash flow (TTM)
-3.677
Growth
Revenue change (TTM)
14.99%
Earnings per share change (TTM)
-65.14%
3-year revenue growth (CAGR)
5.55%
3-year earnings per share growth (CAGR)
-10.76%
Galapagos News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Galapagos stock?
Galapagos (GLPG) has a market cap of $1.7B as of April 04, 2025.
What is the P/E ratio for Galapagos stock?
The price to earnings (P/E) ratio for Galapagos (GLPG) stock is 19.98 as of April 04, 2025.
Does Galapagos stock pay dividends?
No, Galapagos (GLPG) stock does not pay dividends to its shareholders as of April 04, 2025.
When is the next Galapagos dividend payment date?
Galapagos (GLPG) stock does not pay dividends to its shareholders.
What is the beta indicator for Galapagos?
Galapagos (GLPG) has a beta rating of -0.01. This means that it has an inverse relation to market volatility.